Androgen deprivation therapy for prostate cancer and risk of dementia

OBJECTIVES: To study whether androgen deprivation therapy (ADT), the mainstay treatment for advanced and disseminated prostate cancer, is associated with risk of dementia. METHODS: Risk of dementia in men with prostate cancer primarily managed with ADT or watchful waiting (WW) in the Prostate Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, David, Garmo, Hans, Van Hemelrijck, Mieke, Damber, Jan‐Erik, Bratt, Ola, Holmberg, Lars, Wahlund, Lars‐Olof, Stattin, Pär, Adolfsson, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Urological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850189/
https://www.ncbi.nlm.nih.gov/pubmed/30637900
http://dx.doi.org/10.1111/bju.14666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850189/
https://www.ncbi.nlm.nih.gov/pubmed/30637900
http://dx.doi.org/10.1111/bju.14666

Ejemplares similares